The Sudeep Pharma IPO , valued at ₹895 crore, closes for bidding today after steady participation over the first two sessions. The issue consists of a ₹95 crore fresh issue and an ₹800 crore offer for sale. Shares are priced between ₹563 and ₹593 , with a minimum retail investment requirement of ₹14,825. Investor interest has remained consistent as the company positions itself within the specialty ingredients market ahead of allotment and listing timelines.